StockData
XTL Biopharmaceuticals Ltd logo

XTL Biopharmaceuticals Ltd (XTLB) stock

XTLBNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 30, 2026Score 0/30
$1.54−0.06 (-3.75%)

Close on Nov 16, 2026Market cap $14.57MP/E –Yield –

XTL Biopharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

No profit margin figures for XTL Biopharmaceuticals

XTL Biopharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More XTL Biopharmaceuticals figures

See a number that looks wrong?